A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator
- 28 July 2026
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 45 (36) , 3797-3811
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Cell Detection with Star-Convex Polygons2018
- A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerCell, 2018
- Regulation of prostate cancer progression by the tumor microenvironmentCancer Letters, 2016
- Simple and Reproducible Sample Preparation for Single-Shot Phosphoproteomics with High Sensitivity2016
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- PKCδ regulates IL‐12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasisEuropean Journal of Immunology, 2011
- PKC‐mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgensMolecular Carcinogenesis, 2008
- Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidineJournal of Immunological Methods, 1996
- Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applicationsJournal of Immunological Methods, 1994